ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2015) 474 N.R. 235 (FCA)
Linked as:
Extract
ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2015) 474 N.R. 235 (FCA)
No longer available (Autolink)
See the full content of this document
This document cites
- Gilead Sciences Canada Inc. v. Canada (Minister of Health) et al., (2012) 435 N.R. 188 (FCA)
- ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2014) 464 F.T.R. 66 (FC)
- Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
- ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2014) 452 F.T.R. 173 (FC)
- Housen v. Nikolaisen et al., (2002) 219 Sask.R. 1 (SCC)
